Correlation between serum myeloperoxidase with the severity of heart failure in children

Ratih Kumala Sari; Mahrus A Rahman; Gwenny Ichsan Prabowo; Alpha Fardah Athiyyah; Anang Endryanto; Yudi Her Oktaviano

doi:10.53730/ijhs.v6nS9.12355

Authors

Ratih Kumala Sari Child Health Department, Medical Faculty, Universitas Airlangga, Dr Soetomo Academic Hospital, Surabaya, Indonesia
Mahrus A Rahman
mahrus.a@fk.unair.ac.id
Child Health Department, Medical Faculty, Universitas Airlangga, Dr Soetomo Academic Hospital, Surabaya, Indonesia
Gwenny Ichsan Prabowo Biochemistry Department, Medical Faculty, Universitas Airlangga, Dr Soetomo Academic Hospital, Surabaya, Indonesia
Alpha Fardah Athiyyah Child Health Department, Medical Faculty, Universitas Airlangga, Dr Soetomo Academic Hospital, Surabaya, Indonesia
Anang Endryanto Child Health Department, Medical Faculty, Universitas Airlangga, Dr Soetomo Academic Hospital, Surabaya, Indonesia
Yudi Her Oktaviano Cardiovascular Department, Medical Faculty, Universitas Airlangga, Dr Soetomo Academic Hospital, Surabaya, Indonesia

Keywords:

myeloperoxidase, heart failure, congenital heart disease, children

Abstract

Heart failure in children is a global major health problem. Inflammation is an important role in pathophysiology of heart failure. Myeloperoxidase (MPO) included to the inflammation cascade. The objective was to analyze correlation between MPO with severity of heart failure in children. Observational analytic with cross sectional study was conducted on children aged 1 month-18 years with an acyanotic CHD with or without heart failure at Dr. Soetomo General Hospital Surabaya. Bivariate analysis used Mann Whitney test. Multivariate analysis used Kruskal Wallis. Correlation test used Spearman’s test with significance value was p<0.05. A total of 21 subjects, median age was 93 months old. The most common type of acyanotic CHD was VSD. Moderate heart failure was in 28% of subjects, 48% of subjects were mild heart failure. Median value of serum MPO levels in acyanotic CHD with heart failure was 36.25 (7.3-390) pg/ml. There was no differences in the value of serum MPO level in children with acyanotic CHD distinguished by the severity of heart failure (p=0.62). There was no correlation between serum MPO levels with the severity of heart failure in children (p=0.89). We concluded no correlation between serum MPO levels with the severity of heart failure in children.

Downloads

Download data is not yet available.

References

Alameey, I, R, E., Ahmed, H, H., Mahmoud, R, A., Kairy, S, A, and Medany E, A.(2019) Significance of Myeloperoxidase in the Onset of Cardiovascular Disease among Obese Children and Adolescents’, Biomedical and Pharmacological Journal, 12(4): 1647–1659 https://dx.doi.org/10.13005/bpj/1795

Ali, M., et al. (2016) ‘Myeloperoxidase Inhibition Improves Ventricular Function and Remodeling After Experimental Myocardial Infarction’, JACC: Basic to Translational Science, 1(7): 633–643 https://doi.org/10.1016/j.jacbts.2016.09.004

Arifani, R., Rahman, M. A., and Nugraha, J. (2021) Correlation between N-Terminal-Pro-Brain Natriuretic Peptide and Heart Failure in Children with Acyanotic Congenital Heart Disease Left-to-right Shunt, International Journal of Research Publication, 81(1): 83–88 https://doi.org/10.47119/IJRP100811720212119

Alpysbaev, K. S., Djuraev, A. M., & Tapilov, E. A. (2021). Reconstructive and restorative interventions at the proximal end of the thigh and pelvic bones in destructive pathological dislocation of the hip in children after hematogenous osteomyelitis. International Journal of Health & Medical Sciences, 4(4), 367-372. https://doi.org/10.21744/ijhms.v4n4.1779

Blatter, J. A., Noyes, B., and Sweet, S, C. (2018) Chapter 67 - Pediatric Lung Transplantation in Kendig’s Disorders of the Respiratory Tract in Children, 9th edition, 6: 981–991.e4.

Coculescu, B. I., Dinca, G, V., Balaet, C., Manole, G., Balaet, M., and Stocheci C, M. (2018). Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction, Journal of Enzyme Inhibition and Medicinal Chemistry. Taylor & Francis, 33(1): 1292–1298 https://doi.org/10.1080/14756366.2018.1499626

Fayzullaeva, H. D. (2020). Educational environment influence on the pre-school children’s social cognition development. International Journal of Social Sciences and Humanities, 4(2), 13–20. https://doi.org/10.29332/ijssh.v4n2.401

Gilljam, T, Mandalenakis, Z, Dellborg, M, Lappas, G, Eriksson, P, Skoglund, K, and Rosengren, A. (2019). Development of heart failure in young patients with congenital heart disease: a nation-wide cohort study, Open Heart, 6(:e000858):1–7 https://doi.org/10.1136/openhrt-2018-000858

Kolodziej, A. R., Abo-Aly, M., Elsawalhy, E., Campbell, C., Ziada, K, M., and Abdel-Latif, A. (2019). Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Meta-Analysis, Mediators of Inflammation, 2019: 1–9. https://doi.org/10.1155/2019/2872607

Madriago, E. and Silberbach, M. (2010). Heart Failure in Infants and Children, Pediatrics in Review, 31(1): 4–12 http://dx.doi.org/10.1542/pir.31-1-4

Mahrani Y, Nova R, Saleh, M, I., and Rahadianto K, M.(2017). Correlation of heart failure severity and N-terminal pro-brain natriuretic peptide level in children. Paediatrica Indonesiana, 56(6): 315– 319 https://doi.org/10.14238/pi56.6.2016.315-9

Michowitz, Y. et al. (2008). Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure, Israel Medical Association Journal, 10(12): 884–888

Nandi, D., Almond, C, S., and Rossano, J, W. (2017) Chapter 12: Epidemiology and Economics of Pediatric Heart Failure in Heart Failure in the Child and Young Adult: From Bench to Bedside. London, Elsevier Inc: 151-160

Nicholls, S. J, and Hazen, S. L. (2005). Myeloperoxidase and cardiovascular disease, Arteriosclerosis, Thrombosis, and Vascular Biology, 25(6): 1102– 1111. https://doi.org/10.1161/01.ATV.0000163262.83456.6d

Nybo, T., Cai, H., Chuang, C, Y., Gamon, L, F., Rogowska-Wrzesinska, A., and Davies, M, J. (2018). Chlorination and oxidation of human plasma fibronectin by myeloperoxidase-derived oxidants, and its consequences for smooth muscle cell function, Redox Biology. Elsevier B.V., 19: 388–400. https://doi.org/10.1016/j.redox.2018.09.005

Olza et al. (2012). Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children, Diabetes Care, 35(11): 2373–2376 https://doi.org/10.2337%2Fdc12-0614

Pirinccioglu, A, G., Alyan, O, Kizil, G, Kangin, M., and Beyazit, N. (2012). Evaluation of oxidative stress in children with congenital heart defects’, Pediatrics International: 94–98. https://doi.org/10.1111/j.1442-200x.2011.03478.x

Puggia, I., Rowland T.J., Miyamoto, S.D., Sinagra G., and Mestroni L. (2018). Chapter 1: Molecular and Cellular Mechanisms in Heart Failure in Heart Failure in the Child and Young Adult. UK: Elsevier Inc. 1-19 http://dx.doi.org/10.1016/B978-0-12-802393-8.00001-6

Putri, R., Suwarniati R., Fitri L E., Nugroho, S., and Rahman, M, S. (2017). Prominently increased of Mannose-Binding Lectin (MBL) and Myeloperoxidase (MPO) levels in severe valve regurgitation and Heart Failure of Rheumatic Heart Disease, Journal of Tropical Life Science, 7(2): 108–114 https://doi.org/10.11594/jtls.07.02.04

Reichlin, T. et al. (2010). Use of myeloperoxidase for risk stratification in acute heart failure, Clinical Chemistry, 56(6): 944–951 https://doi.org/10.1373/clinchem.2009.142257

Sibetcheu, A, T., Agbor, V, N., Nyaga, U, F., Bigna, J, J., and Noubiap, J.J. (2018). Epidemiology of heart failure in pediatric populations in low- and middle-income countries: A protocol for a systematic review, Systematic Reviews, 7(1): 1–6. https://doi.org/10.1186/s13643-018-0717-6

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

Tang, W, H, W., Brennan, M,-L., Philip, K., Tong,W., Mann, S., Lente, F. V., and Hazen, S, L. (2006). Plasma myeloperoxidase levels in patients with chronic heart failure’, American Journal of Cardiology, 98(6): 796–799 https://doi.org/10.1016/j.amjcard.2006.04.018

Tang, W. H. W. et al. (2007). Prognostic Value and Echocardiographic Determinants of Plasma Myeloperoxidase Levels in Chronic Heart Failure, Journal of the American College of Cardiology, 49(24): 2364–2370 https://doi.org/10.1016/j.jacc.2007.02.053

Tang, W, H, W., Shrestha, K., Troughton, R, W., Borowski, A, G., and Klein, A, L. (2011). Integrating Plasma High-Sensitivity C - reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure, Congestive Heart Failure, 17(3): 105–109 https://doi.org/10.1111/j.1751-7133.2011.00221.x

Ungvari, Z, Gupte, S, A., Recchia, F, A., Batkai, S., and Pacher, Pl. (2005). Role of Oxidative-Nitrosative Stress and Downstream Pathways in Various Forms of Cardiomyopathy and Heart Failure’, Current Vascular Pharmacology, 3(3): 221–229 https://doi.org/10.2174%2F1570161054368607

Zhang, L, Liu, B., Li, H., Wang, C., Yang, S., and Li, Z (2022). Epidemiology of congenital heart disease in Jinan, China from 2005 to 2020 : a time trend analysis, Frontiers in Cardiovascular Medicine, 9(815137):1–10 https://doi.org/10.3389/fcvm.2022.815137